Articles for author: Russ Cohen

Russ Cohen

Crypto Market Update: Q3 2024 in Review

A turbulent Q3 in the crypto market was marked by price volatility and shifts in investor sentiment. Popular cryptocurrency Bitcoin, often seen as a bellwether for the industry, experienced sharp price corrections at the start of each month, with July and August witnessing declines exceeding 12 percent. Meanwhile, Ethereum’s performance in Q3 showed signs of ...

Russ Cohen

ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 31, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ALLR. Class Period: May 17, 2022 – July 19, 2024Lead Plaintiff Deadline: November 12, 2024 If you wish ...

Russ Cohen

Top 4 Financials Stocks That Are Preparing To Pump In Q4

The most oversold stocks in the financials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better ...

Russ Cohen

Best Income Stocks to Buy for November 5th

Here are three stocks with buy rank and strong income characteristics for investors to consider today, November 5th: American Assets Trust, Inc. AAT: This self-administered real estate investment trust has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days. American Assets Trust, Inc. Price and Consensus American ...

Russ Cohen

This Is What Whales Are Betting On MicroStrategy

Financial giants have made a conspicuous bullish move on MicroStrategy. Our analysis of options history for MicroStrategy MSTR revealed 260 unusual trades. Delving into the details, we found 40% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 68 were puts, with a value of $5,924,510, and 192 ...

Russ Cohen

Should Investors Buy MercadoLibre Stock Ahead of Q3 Earnings?

MercadoLibre MELI is scheduled to release its third-quarter 2024 results on Nov. 6.  For the third quarter, the Zacks Consensus Estimate for revenues is pegged at $5.25 billion, suggesting a rise of 39.73% from the prior-year quarter’s reported figure. The Zacks Consensus Estimate for third-quarter earnings is pegged at $11.27 per share, suggesting a jump ...

Russ Cohen

Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript

Image source: The Motley Fool. Vertex Pharmaceuticals (NASDAQ: VRTX)Q3 2024 Earnings CallNov 04, 2024, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, and welcome to the Vertex Pharmaceuticals third quarter 2024earnings call All participants will be in a listen-only mode. [Operator instructions] After today’s presentation, there will ...

Russ Cohen

NVIDIA Trading at a Low P/E Multiple: Time to Buy the Stock?

NVIDIA Corporation’s NVDA current valuation suggests that the stock is available at a discounted price compared with the industry average. NVDA stock currently trades at a trailing 12-month price-to-earnings (P/E) ratio of 63.28, which is significantly lower than the Zacks Semiconductor – General industry average of 72.04. Image Source: Zacks Investment Research What makes the ...

Russ Cohen

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit

LOS ANGELES, Oct. 29, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX. Class Period: February 2024 IPOLead Plaintiff Deadline: November 25, 2024 If you wish to serve as lead plaintiff ...